Skip to content
Company Analysis

PetMed Express, Inc. PETS

A comprehensive view of key metrics, scores, and financial health for PetMed Express, Inc.

Overview of PetMed Express, Inc.

PETS NMS
Healthcare Pharmaceutical Retailers Framework: General Corporate Micro Cap
PetMed Express, Inc. (PETS), is a Micro Cap company, in the Pharmaceutical Retailers industry, last closed at $1.20, about 702.5% undervalued vs fair value, -51.0% 1Y return, ranked 1115/1145 in sector.
Metrics Gross Margin 28.1% Div Yield 0.04%
USD 1.20
0.84%
(Delayed)
• Vol 90d: 40.0%
52-Week Range
Market Cap
$26.00M
Enterprise Value
$12.93M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 94%
Confidence: 93%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.1800petmeds.com
HQ Delray Beach, FL
Employees 173
Fiscal year Mar 31

Next Events

Earnings Nov 10 Call: Nov 10

Fair Value Snapshot

Bear Base Bull
$8
$10
$11
Current: $1.20 +703% vs base

Engine Room Money Flow™

Micro Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$179.0M
-34.7%%
Gross Profit
$50.2M
-40.8%%
Operating Income
-$58.7M
-618.9%%
Net Income
-$57.3M
-667.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio FY2026
57.6%

Operating Cash Flow / Net Income

FCF / Net Income - not meaningful while net income is negative (a near-100% ratio here only reflects cash burn tracking accounting losses, not earnings quality)

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating PetMed Express, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
33
/100
Developing
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key risks

  • ROIC Below WACC or Peers ROIC at 3.7th percentile suggests inefficient capital deployment.
  • Scale Without Profitability Despite scale, profitability lags peers (score 0.34), suggesting limited competitive advantage.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
26
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing PETS's balance between Growth (31.0%), Profitability (21.4%), and Safety (47.6%). Growth 31% Safety 48% Profitability 21%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

32th percentile vs peers
32
Key Signals
Rev Growth YoY 10.7% 70p Revenue CAGR 3Y -10.2% 13p EPS Growth YoY -2.45 8p TSR -45.6% 12p
Strengths
  • D/E Ratio in top 20% of peers (1.8%, 82th percentile)
  • Net Debt/EBITDA in top 20% of peers (-10.85, 97th percentile)
  • Conservative leverage compared to industry peers
Risks
  • EPS Growth YoY in bottom 20% of peers (-2.45)

Profitability

22th percentile vs peers
22
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

49th percentile vs peers
50
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for PetMed Express, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$9.63
- - -
+702.5% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000